Largest ever Parkinson’s research trial is starting now
Date
News
Date
A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
Date
New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
Date
A new clinical study published in the journal Parkinsonism and Related Disorders links higher caffeine consumption to slower development of Parkinson's symptoms after diagnosis.
Date
Positive results from a trial of ultrasound therapy for treating tremor have been published, with potential benefits for controlling Parkinson's symptoms.
Date
Researchers from the UCL have identified a way to detect Parkinson's through the eyes in a rat model of the condition.
Date
New research suggests that severe head injury, which causes loss of consciousness, could be linked to increased risk of developing Parkinson's.
Date
A year after Duodopa was funded by NHS England we reflect on the importance of campaigning for people affected by Parkinson's and how you can get involved.
Date
7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Date
Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.
Date
Our Media team has been awarded a special runners-up prize in the PR team of the year category at the Charity Times Awards for their work on highlighting Parkinson's Awareness Week 2012.